Lupeol, A Novel Fuit and Vegetable Based Triterpene for Prostate Cancer

羽扇豆醇,一种治疗前列腺癌的新型水果和植物三萜

基本信息

  • 批准号:
    7321036
  • 负责人:
  • 金额:
    $ 7.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-01 至 2009-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): It is estimated that 234,460 new prostate cancer cases will be diagnosed and approximately 27,350 prostate cancer-related deaths are predicted in the US alone in the year 2006. Persistence of isolated cancer cells (even after surgery and androgen-ablation therapy), their proliferation, androgen-independence and invasion to distant sites is the major cause of deaths in human prostate cancer patients. Aberration in the levels and functioning of multiple proteins or molecular pathways including beta catenin, nuclear factor kappa B and phosphotidyl inositol 3 kinase /Akt signaling network, has been associated with the androgen-independence, proliferation, invasion and chemoresistance of prostate cancer cells. Since most of the chemotherapeutic agents generally target a specific protein or a molecular pathway, they most often fail to inhibit the growth of advanced prostate cancer in preclinical and clinical settings. Thus, it is important to identify novel agents with an ability to target multiple molecular pathways. It is increasingly appreciated that chemoprevention through diet-based natural agents could be an effective approach to prevent and treat prostate cancer in humans. Based on our published studies and preliminary data, we believe that Lupeol, a non-nutrient and non-toxic natural agent present in strawberry, grapes, mango, figs, olive and vegetables, could be an ideal chemopreventive and therapeutic agent with an ability to act on multiple molecular pathways. We hypothesize that Lupeol has the potential to kill highly aggressive and chemoresistant prostate cancer cells while sparing normal cells, inhibit their proliferation and invasion through the modulation of beta catenin, nuclear factor kappa B and phosphotidyl inositol 3 kinase /Akt signaling network. It is important to emphasize that, consistent with current NCI opinion, the term "chemoprevention" is used in its broadest sense in this application, i.e. in a partially therapeutic as well as purely preventive context. To achieve our goal, we propose two specific aims: (1) to investigate the anti-proliferative potential of Lupeol against androgen-independent prostate cancer cells, and to define its mechanism of action under cell culture conditions and (2) to investigate whether Lupeol possesses the chemopreventive and/or chemotherapeutic effects against the tumorigenicity of androgen-insensitive prostate cancer cells in an animal model. We believe that this application will be extremely valuable in providing a novel fruit and vegetable based agent for chemoprevention and possibly for treating prostate cancer
描述(由申请人提供): 据估计,2006 年,仅在美国,将诊断出 234,460 例新的前列腺癌病例,预计将有约 27,350 例前列腺癌相关死亡。孤立的癌细胞的持续存在(即使在手术和雄激素消融治疗之后)、它们的增殖、雄激素非依赖性和远处侵袭是人类前列腺癌患者死亡的主要原因。多种蛋白质或分子通路(包括β连环蛋白、核因子κB和磷脂酰肌醇3激酶/Akt信号网络)的水平和功能异常与前列腺癌细胞的雄激素非依赖性、增殖、侵袭和化疗耐药有关。由于大多数化疗药物通常针对特定蛋白质或分子途径,因此它们在临床前和临床环境中通常无法抑制晚期前列腺癌的生长。因此,识别能够靶向多种分子途径的新型药物非常重要。人们越来越认识到,通过基于饮食的天然药物进行化学预防可能是预防和治疗人类前列腺癌的有效方法。根据我们已发表的研究和初步数据,我们相信羽扇豆醇是一种存在于草莓、葡萄、芒果、无花果、橄榄和蔬菜中的非营养且无毒的天然物质,可能是一种理想的化学预防和治疗剂,能够作用于多种分子途径。我们假设羽扇豆醇有可能杀死高度侵袭性和化学耐药性的前列腺癌细胞,同时保留正常细胞,通过调节 β 连环蛋白、核因子 kappa B 和磷脂酰肌醇 3 激酶 /Akt 信号网络抑制其增殖和侵袭。需要强调的是,与目前 NCI 的观点一致,术语“化学预防”在本申请中以其最广泛的含义使用,即在部分治疗以及纯粹预防的背景下。为了实现我们的目标,我们提出了两个具体目标:(1)研究羽扇豆醇对雄激素非依赖性前列腺癌细胞的抗增殖潜力,并确定其在细胞培养条件下的作用机制;(2)研究羽扇豆醇是否在动物模型中对雄激素不敏感的前列腺癌细胞的致瘤性具有化学预防和/或化学治疗作用。我们相信,该应用对于提供一种新的基于水果和蔬菜的化学预防剂以及可能用于治疗前列腺癌非常有价值

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mohammad Saleem Bhat其他文献

Mohammad Saleem Bhat的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mohammad Saleem Bhat', 18)}}的其他基金

Novel targeted chemo/immunotherapy approach for localized and metastatic CaP
针对局部和转移性 CaP 的新型靶向化疗/免疫治疗方法
  • 批准号:
    10415649
  • 财政年份:
    2021
  • 资助金额:
    $ 7.35万
  • 项目类别:
Novel gene that determines metastatic phenotype in African-American men with PCa
决定非裔美国前列腺癌​​男性转移表型的新基因
  • 批准号:
    9103022
  • 财政年份:
    2015
  • 资助金额:
    $ 7.35万
  • 项目类别:
Delaying the Hormone Refractory Prostate Cancer by a Dietary Triterpene Lupeol
通过膳食三萜羽扇豆醇延缓激素难治性前列腺癌的发生
  • 批准号:
    7835621
  • 财政年份:
    2009
  • 资助金额:
    $ 7.35万
  • 项目类别:
Delaying the Hormone Refractory Prostate Cancer by a Dietary Triterpene Lupeol
通过膳食三萜羽扇豆醇延缓激素难治性前列腺癌的发生
  • 批准号:
    7661136
  • 财政年份:
    2009
  • 资助金额:
    $ 7.35万
  • 项目类别:
Lupeol, A Novel Fuit and Vegetable Based Triterpene for Prostate Cancer
羽扇豆醇,一种治疗前列腺癌的新型水果和植物三萜
  • 批准号:
    7472599
  • 财政年份:
    2007
  • 资助金额:
    $ 7.35万
  • 项目类别:

相似国自然基金

HJURP调控PRDX1增加雄激素受体蛋白稳定性导致前列腺癌细胞对恩扎卢胺耐药的机制
  • 批准号:
    82373188
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
雄激素受体AR介导雄激素调控林麝泌香的分子机制研究
  • 批准号:
    32370560
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
雄激素受体通过调控Lcn2表达抵抗高脂饮食诱导的肥胖机理研究
  • 批准号:
    82300938
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
PAK1介导前列腺癌抗雄激素受体治疗交叉耐药的机制研究
  • 批准号:
    82373362
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
靶向Sub-LBP的新型雄激素受体拮抗剂的发现及其抗前列腺癌活性研究
  • 批准号:
    82304381
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

University of Wisconsin Prostate SPORE
威斯康星大学前列腺孢子
  • 批准号:
    10555398
  • 财政年份:
    2023
  • 资助金额:
    $ 7.35万
  • 项目类别:
Targeting the Plk1/Pdcd4/mTORC2 Signaling to Treat Castration-Resistant Prostate Cancer
靶向 Plk1/Pdcd4/mTORC2 信号传导治疗去势抵抗性前列腺癌
  • 批准号:
    10731943
  • 财政年份:
    2023
  • 资助金额:
    $ 7.35万
  • 项目类别:
Project 3: Extending Clinical Benefit by Selective Treatment of Resistant Lesions in mCRPC
项目 3:通过选择性治疗 mCRPC 耐药病变来扩大临床获益
  • 批准号:
    10555402
  • 财政年份:
    2023
  • 资助金额:
    $ 7.35万
  • 项目类别:
Comprehensive Analyses of HOXB13-regulated Transcriptional programs critical for Prostate Cancer Progression
HOXB13 调控的转录程序的综合分析对前列腺癌进展至关重要
  • 批准号:
    10904447
  • 财政年份:
    2023
  • 资助金额:
    $ 7.35万
  • 项目类别:
Mechanisms by which histone methyltransferases regulate nuclear receptor activity and response to therapy in hormone-driven tumors.
组蛋白甲基转移酶调节核受体活性和激素驱动肿瘤治疗反应的机制。
  • 批准号:
    10563751
  • 财政年份:
    2023
  • 资助金额:
    $ 7.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了